Clinical trials: Nonrevascularizable Critical Ischemia of the Lower Limbs
Nonrevascularizable Critical Ischemia of the Lower Limbs
Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy
It has been demonstrated the feasibility, safety and effectiveness of mesenchymal stem cells derived from lipoaspirate for treating various pathologies fistula.
- Trial name
- HULPVAS (NCT01824069)
- Testing
- Intramuscular injection of a suspension of adult mesenchymal stem cells derived
- Where
- Spain
- Volunteers
- 10 people
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz